Arrow Financial’s Bio-Techne TECH Stock Holding History

Arrow Financial’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-54	Closed	-$4.17K	–	347
2023 Q4	$4.17K	Buy	+54	New	+$3.56K	﹤0.01%	307

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Arrow Financial's TECH Position: Q1 2024 in Review

Arrow Financial sold out of Bio-Techne (TECH) in Q1 2024, closing a stake of 54 shares — an estimated $4.17K sold.

Arrow Financial first reported a position in TECH in Q4 2023 and held it in 1 quarter. The position peaked at $4.17K in Q4 2023. 557 funds tracked by Wall St. Rank hold TECH as of Q1 2024.

Arrow Financial reported no remaining Bio-Techne position as of Q1 2024 after selling out during the quarter.
Arrow Financial sold 54 Bio-Techne shares in Q1 2024, an estimated $4.17K.
Arrow Financial first reported a position in Bio-Techne in Q4 2023 and held it in 1 quarter.
Arrow Financial's Bio-Techne position peaked at $4.17K in Q4 2023.
557 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2024.

Based on Arrow Financial's 13F filing for Q1 2024, filed 21 May 2024.